SAMHD1 and B-cell chronic lymphocytic leukemia: tSNE maps showed a marked reduction of CLL B cells upon forodesine and dG treatment in cells from SAMHD1-mutated patients, but not in the SAMHD1 WT groups (Figures 5E and S5).